- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
Devyser RHD is a non-invasive diagnostic test for RhD status determination of a fetus from 10tt by analyzing fetal cfDNA isolated from maternal plasma.
Thanks to the non-invasive approach, high sensitivity, low DNA input and quick workflow, it is suitable for screening RhD- mothers.
The test is based on the amplification of exon 4 of the RHD gene (single-exon design) and GAPDH gene as an internal control using rtPCR (FAM, VIC).
All reagents including positive control (RhD+ gDNA) and negative control (NTC) are included in the kit.
The product is available in packs of 78 reactions, which can be used to analyze up to 25 samples in triplicate, a positive control in duplicate and a negative control.
The product is compatible with LightCycler 480, ABI 7500, QuantStudio 6 and 7 instruments.
NEW! The Devyser RHD product is newly certified according to the new EU IVDR regulation (2017/746).
For more information, please contact us by e-mail: diagnostika@pentagen.cz